PHETA1
Sesquipedalian-1
Also known as: FAM109A, FLJ32356, IPIP27A, SES1, SESQ1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N4B1
- Gene
- PHETA1
- Ensembl
- ENSG00000198324
- Chromosome
- 12
- Canonical length
- 249 aa
- Protein class
- Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that localizes to the endosome and interacts with the enzyme, inositol polyphosphate 5-phosphatase OCRL-1. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
249 residues, UniProt reviewed canonical sequence.
>Q8N4B1|PHETA1
1 MKLNERSLAF YATCDAPVDN AGFLYKKGGR HAAYHRRWFV LRGNMLFYFE DAASREPVGV
61 IILEGCTVEL VEAAEEFAFA VRFAGTRART YVLAAESQDA MEGWVKALSR ASFDYLRLVV
121 RELEQQLAAV RGGGGMALPQ PQPQSLPLPP SLPSALAPVP SLPSAPAPVP ALPLPRRPSA
181 LPPKENGCAV WSTEATFRPG PEPPPPPPRR RASAPHGPLD MAPFARLHEC YGQEIRALRG
241 QWLSSRVQPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PHETA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 23 nTPM
- duodenum: 23 nTPM
- stomach: 15 nTPM
- pancreas: 14 nTPM
- spleen: 11 nTPM
- liver: 10 nTPM
Single-cell type
- early spermatids: 58 nCPM
- enterocytes: 56 nCPM
- foveolar cells: 44 nCPM
- mucous neck cells: 35 nCPM
- colonocytes: 26 nCPM
- alveolar cells type 1: 25 nCPM
Immune cell
- myeloid DC: 3 nTPM
- intermediate monocyte: 1.8 nTPM
- non-classical monocyte: 1.8 nTPM
- classical monocyte: 1.2 nTPM
- naive B-cell: 0.9 nTPM
- total PBMC: 0.9 nTPM
Brain region
- medulla oblongata: 11 nTPM
- thalamus: 11 nTPM
- hypothalamus: 9.8 nTPM
- amygdala: 9.5 nTPM
- midbrain: 9.3 nTPM
- pons: 8.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0.01
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PHETA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PHETA1 as an antibody target. Whether an autoantibody or antibody against PHETA1 could matter depends on whether native PHETA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PHETA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PHETA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...